Detail akcie Stryker online

Business Summary: Stryker Corporation is a medical technology company. It offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and others. It offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs. It is also focused on treating calcified arterial disease.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Stryker Corp revenues increased 3% to $6.02B. Net income increased 14% to $745M. Revenues reflect Orthopaedics segment increase of 19% to $2.81B, International segment increase of 8% to $1.54B, United States segment increase of 1% to $4.5B. Net income benefited from Orthopaedic segment income increase of 32% to $846M, Corporate and Other segment loss decrease of 21% to $610M.